GAITHERSBURG, Md., March 11 /PRNewswire-FirstCall/ -- Iomai Corporation (NASDAQ:IOMI) today announced that Stanley C. Erck, the company's president and chief executive officer, will present at the Cowen and Company 28th Annual Health Care Conference in Boston on Monday, March 17. Mr. Erck's presentation will begin at 4:45 p.m. Eastern Time. A breakout session following the presentation will begin at 5:30 p.m. The conference will be held at the Boston Marriott Copley Place. Mr. Erck's presentation will include a review of the company's clinical and preclinical programs, including plans to move into a pivotal Phase 3 trial of its patch-based, needle-free vaccine for travelers' diarrhea, as well as an overview of the company's partnering strategy. To access the live audio webcast or the subsequent archived recording, log on to the Investor Relations section on the Overview page of the Iomai website at http://www.iomai.com/. Please connect to Iomai's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary. ABOUT IOMAI CORPORATION Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI, discovered by researchers at the Walter Reed Army Institute of Research, taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin (Langerhans cells) to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. Iomai currently has four product candidates in development: three targeting influenza and pandemic flu and one to prevent travelers' diarrhea. For more information on Iomai, please visit http://www.iomai.com/. DATASOURCE: Iomai Corporation CONTACT: Russell P. Wilson, Senior Vice President, Chief Financial Officer and General Counsel of Iomai Corporation, +1-301-556-4478, ; or Brian Reid of WeissComm Partners, Inc., +1-703-402-3626, , for Iomai Corporation Web site: http://www.iomai.com/

Copyright

Grafico Azioni Iomai Corp (MM) (NASDAQ:IOMI)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Iomai Corp (MM)
Grafico Azioni Iomai Corp (MM) (NASDAQ:IOMI)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Iomai Corp (MM)